Esticast Logo
Get In Touch!

Levothyroxine Market By Product Type ( Tablet, Intravenous Injection ), By Distribution Channel ( Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), Industry Trends, Estimation & Forecast, 2017 - 2025

  • Published On: Apr, 2018
  • Category: Healthcare
  • Pages: 178
Levothyroxine Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Levothyroxine is the most common medication which is prescribed to the patients dealing with hypothyroidism. Levothyroxine is also called by various other names in the market such as T4, thyroxine and symthroid. In hypothyroidism, the thyroid gland gets underactive and becomes unable to generate appropriate amount of thyroid hormone. Levothyroxine works as an analogue hormone which is used for the hormone replacement in the patients dealing with thyroid issues. The constantly rising number of patients suffering from hypothyroidism coupled with the continuously increasing awareness among common masses regarding proper treatment of thyroid issues is acting as a driving factor for the market growth. Geographically, North America is expected to hold a considerably large market share as a result of high occurrence of hypothyroidism in the region, improper lifestyle and unhealthy dietary habits. As per a data released by American Thyroid Association, more than 12% of the U.S. population will develop a thyroid condition during their lifetime. Approximately 20 million Americans have thyroid disease in the current scenario. Moreover, hypothyroidism can also result in the generation of goiter and even more critical issues such as thyroid cancer, especially among women. This is compelling the government organizations to spread awareness among people through the means of campaigns and seminars regarding women and maternal health, which acts as a propelling factor for the levothyroxine market growth. As per a research, women are (8-10) times more prone to hypothyroidism and might face severe problematic issues such as mood swings, heavy menstrual flow, sudden weight gain and even knee joint pains. Due to this rise in thyroid disorder patient population globally, rise in demand for these drugs for hypothyroidism, especially in the developing and developed regions is leading the key thyroid drug manufacturers to conduct R&D activities for the development of advance therapeutics. However, factors such as availability of alternative generic drugs and various problematic side effects of levothyroxine might hinder the market growth. The report provides detailed qualitative and quantitative analysis of the Global Levothyroxine Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Levothyroxine Market Segmentation

By Product Type • Tablet • Intravenous Injection By Distribution Channel • Hospital Pharmacy • Retail Pharmacy • Online Pharmacy By Geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources

CHAPTER 2. LEVOTHYROXINE MARKET OVERVIEW
2.1. LEVOTHYROXINE MARKET INTRODUCTION
2.2. GLOBAL LEVOTHYROXINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global Levothyroxine Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3. GLOBAL LEVOTHYROXINE MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global Levothyroxine Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4. GLOBAL LEVOTHYROXINE MARKET REVENUE AND GROWTH RATE, 2017-2025 22
2.4.1. Global Levothyroxine Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL LEVOTHYROXINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global Levothyroxine Consumption (VOLUME) and Growth Rate (%), (2017-2025)
2.6. GLOBAL LEVOTHYROXINE MARKET PRICE TREND, 2017-2025
2.6.1. Global Levothyroxine Market Price Trend and Growth Rate (%), (2017-2025)

CHAPTER 3. GLOBAL LEVOTHYROXINE MARKET BY PRODUCT TYPE, 2017-2025
3.1. TABLET
3.2. INTRAVENOUS INJECTION
3.3. GLOBAL LEVOTHYROXINE MARKET REVENUE BY PRODUCT TYPE, 2017-2025
3.3.1. Global Levothyroxine Market Revenue (Million USD) and Share (%) By Product Type, 2017-2025
3.3.2. Tablet Market Revenue and Growth Rate, 2017-2025
3.3.3. Intravenous Injection Market Revenue and Growth Rate, 2017-2025
3.4. GLOBAL LEVOTHYROXINE MARKET PRODUCTION BY PRODUCT TYPE, 2017-2025
3.4.1. Global Levothyroxine Market Production (Volume) and Share (%) By Product Type, 2017-2025
3.4.2. Tablet Market Production and Growth Rate, 2017-2025
3.4.3. Intravenous Injection Market Production and Growth Rate, 2017-2025

CHAPTER 4. GLOBAL LEVOTHYROXINE MARKET BY DISTRIBUTION CHANNEL, 2017-2025
4.1. HOSPITAL PHARMACY
4.2. RETAIL PHARMACY
4.3. ONLINE PHARMACY
4.4. GLOBAL LEVOTHYROXINE MARKET REVENUE BY DISTRIBUTION CHANNEL, 2017-2025
4.4.1. Global Levothyroxine Market Revenue (Million USD) and Share (%) By Distribution Channel, 2017-2025
4.4.2. Hospital Pharmacy Market Revenue and Growth Rate, 2017-2025
4.4.3. Retail Pharmacy Market Revenue and Growth Rate, 2017-2025
4.4.4. Online Pharmacy Market Revenue and Growth Rate, 2017-2025
4.5. GLOBAL LEVOTHYROXINE MARKET CONSUMPTION BY DISTRIBUTION CHANNEL, 2017-2025
4.5.1. Global Levothyroxine Market Consumption (Volume) and share (%) By Distribution Channel, 2017-2025
4.5.2. Hospital Pharmacy Market Consumption and Growth Rate, 2017-2025
4.5.3. Retail Pharmacy Market Consumption and Growth Rate, 2017-2025
4.5.4. Online Pharmacy Market Consumption and Growth Rate, 2017-2025

CHAPTER 5. GLOBAL LEVOTHYROXINE MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL LEVOTHYROXINE MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global Levothyroxine Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 6. GLOBAL LEVOTHYROXINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL LEVOTHYROXINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. Global Levothyroxine Market Production (Volume) and Share (%) By Region, 2017-2025
6.1.2. Global Levothyroxine Market Consumption (Volume) and Share (%) By Region, 2017-2025
6.1.3. North America Market Production and Consumption, 2017-2025
6.1.4. Europe Market Production and Consumption, 2017-2025
6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
6.1.6. South America Market Production and Consumption, 2017-2025
6.1.7. Rest of the World Market Production and Consumption, 2017-2025

CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART

CHAPTER 8. GLOBAL LEVOTHYROXINE MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL LEVOTHYROXINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. Global Levothyroxine Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
8.2. GLOBAL LEVOTHYROXINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. Global Levothyroxine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
8.3. LEVOTHYROXINE MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. Levothyroxine Market Share (%) of Top 3 Manufacturers
8.3.2. Levothyroxine Market Share (%) of Top 5 Manufacturers

CHAPTER 9. GLOBAL LEVOTHYROXINE MANUFACTURERS ANALYSIS
9.1. LGM PHARM
9.1.1. Business Overview
9.1.2. Company Basic Information
9.1.3. Levothyroxine Product Details
9.1.4. LGM Pharm Levothyroxine Production, Revenue and Gross Margin
9.2. TAJ GROUP
9.2.1. Business Overview
9.2.2. Company Basic Information
9.2.3. Levothyroxine Product Details
9.2.4. Taj Group Levothyroxine Production, Revenue and Gross Margin
9.3. BERLIN-CHEMIE
9.3.1. Business Overview
9.3.2. Company Basic Information
9.3.3. Levothyroxine Product Details
9.3.4. Berlin-Chemie Levothyroxine Production, Revenue and Gross Margin
9.4. MERCK SERONO
9.4.1. Business Overview
9.4.2. Company Basic Information
9.4.3. Levothyroxine Product Details
9.4.4. Merck Serono Levothyroxine Production, Revenue and Gross Margin
9.5. BHAARAT PHARMACEUTICAL
9.5.1. Business Overview
9.5.2. Company Basic Information
9.5.3. Levothyroxine Product Details
9.5.4. Bhaarat Pharmaceutical Levothyroxine Production, Revenue and Gross Margin
9.6. MANUS AKTTEVA
9.6.1. Business Overview
9.6.2. Company Basic Information
9.6.3. Levothyroxine Product Details
9.6.4. Manus Aktteva Levothyroxine Production, Revenue and Gross Margin
9.7. SANDOZ
9.7.1. Business Overview
9.7.2. Company Basic Information
9.7.3. Levothyroxine Product Details
9.7.4. Sandoz Levothyroxine Production, Revenue and Gross Margin
9.8. SHENZHEN ZHONGLIAN PHARMACEUTICAL
9.8.1. Business Overview
9.8.2. Company Basic Information
9.8.3. Levothyroxine Product Details
9.8.4. Shenzhen Zhonglian Pharmaceutical Levothyroxine Production, Revenue and Gross Margin
9.9. SICHUAN HAIRONG PHARMACEUTICAL
9.9.1. Business Overview
9.9.2. Company Basic Information
9.9.3. Levothyroxine Product Details
9.9.4. Sichuan Hairong Pharmaceutical Levothyroxine Production, Revenue and Gross Margin

CHAPTER 10. LEVOTHYROXINE MARKET VALUE CHAIN ANALYSIS
10.1. LEVOTHYROXINE INDUSTRIAL CHAIN ANALYSIS
10.2. LEVOTHYROXINE KEY RAW MATERIALS ANALYSIS
10.2.1. Key Raw Materials
10.2.2. Price Trend of Key Raw Materials
10.2.3. Key Suppliers of Raw Materials
10.3. CONSUMER ANALYSIS
10.3.1. Consumer 1
10.3.2. Consumer 2
10.3.3. Consumer 3
10.3.4. Consumer 4

• LGM Pharma
• Taj Group
• Berlin-Chemie
• Merck Serono
• Bhaarat Pharmaceutical
• Manus Aktteva
• Sandoz
• Shenzhen Zhonglian Pharmaceutical
• Sichuan Hairong Pharmaceutical

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS

Esticast Logo

CORPORATE OFFICE

location  (US)

1055 West 7th Street, Los Angeles, CA 90017 (P) US

phone  +1-213-262-0704
location  (APAC Address)

Office No. 407, Navale Icon IT Park, Near Navale Bridge, Narhe, Pune, Maharashtra 411041

phone  +91-959-503-5024

COMPANY

SECURE ONLINE PAYMENTS

  • visa
  • mastercard
  • amex
  • discover

FOLLOW US

  • facebook
  • linkedin
  • phone
  • youtube
© 2022 | All Rights Reserved by Esticast Research & Consulting